Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Innovative Industrial Properties Inc (IIPR) vs Tilray Brands Inc (TLRY) Price & Performance

Innovative Industrial Properties IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Innovative Industrial Properties Inc vs Tilray Brands Inc — how do they compare? Innovative Industrial Properties Inc trades at $51.93 (market cap $1.43B), while Tilray Brands Inc trades at $3.53 (market cap $530.54M). The key difference: Innovative Industrial Properties Inc is far larger — about 2.7× Tilray Brands Inc's market cap, and Innovative Industrial Properties Inc pays a 14.64% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Innovative Industrial Properties Inc for 86 Days and Tilray Brands Inc for 31 Days on average.

IIPRTLRY
Market Cap
$1.43B$530.54M
Volume
394,2229,099,075
Sector
Real EstateHealth
52-Week High
$64.67$21.00
52-Week Low
$44.58$3.57
Typical Hold Time
86 Days31 Days
Enterprise Value
$1.96B$684.46M
Dividend Yield
14.64%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Innovative Industrial Properties Inc

IIPR trades at $51.87, up 1.25% on the day, with a bearish technical signal from moving averages. The stock shows mixed earnings, beating in Q2 but missing in Q1, with revenue declining to $266 million in 2025. Valuation ratios appear attractive with a P/E of 11.75 and P/B of 0.83, while the company maintains a high net income margin of 52.27%. Recent news highlights a $245 million mezzanine loan commitment and a declared $1.90 dividend.

The outlook is cautious due to declining revenue and negative net cash flow in 2025, offset by strong profitability and a discounted valuation. Risks include tenant defaults and dividend sustainability concerns, but analyst consensus suggests upside with a $84.67 price target. The stock presents a high-yield opportunity with significant re-rating potential if operational challenges are managed.

Tilray Brands Inc

Tilray Brands (TLRY) trades at $3.50, down 5.79% on the day and near its 52-week low. The stock shows bearish technical signals with negative moving averages and recent earnings misses across four consecutive quarters. Despite revenue growth to $821 million in 2025, the company reported a substantial net loss of $2.19 billion, driven by impairment charges and high operating costs. Analyst sentiment remains cautious with 65% hold ratings, though the consensus price target of $65.01 suggests significant potential upside from current levels.

The outlook remains challenging with persistent profitability issues and negative cash flow from operations. Investment opportunity exists if Tilray can achieve projected 2026 revenue growth to $915 million and reduce losses. Key risks include ongoing operational inefficiencies, competitive pressures in the cannabis market, and regulatory uncertainty. The stock's current valuation at 0.44 P/S and 0.33 P/B may attract value investors betting on a turnaround.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IIPR
5% Buy95% Sell
Avg holding period · 86 Days
TLRY
54% Buy46% Sell
Avg holding period · 31 Days

Top news

Latest headlines on both assets

About Innovative Industrial Properties Inc

Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.

Read more on IIPR →

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY →